
Dave A. Ghatt
Examiner (ID: 9104)
| Most Active Art Unit | 2854 |
| Art Unit(s) | 2854, 3307 |
| Total Applications | 428 |
| Issued Applications | 393 |
| Pending Applications | 6 |
| Abandoned Applications | 29 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4192647
[patent_doc_number] => 06043223
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'Enhanced opening of abnormal brain tissue capillaries'
[patent_app_type] => 1
[patent_app_number] => 8/968169
[patent_app_country] => US
[patent_app_date] => 1997-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5314
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043223.pdf
[firstpage_image] =>[orig_patent_app_number] => 968169
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/968169 | Enhanced opening of abnormal brain tissue capillaries | Nov 11, 1997 | Issued |
Array
(
[id] => 4157463
[patent_doc_number] => 06156728
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Treatment of inner ear hair cells'
[patent_app_type] => 1
[patent_app_number] => 8/963596
[patent_app_country] => US
[patent_app_date] => 1997-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 17363
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156728.pdf
[firstpage_image] =>[orig_patent_app_number] => 963596
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/963596 | Treatment of inner ear hair cells | Oct 30, 1997 | Issued |
Array
(
[id] => 4086910
[patent_doc_number] => 06017882
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-25
[patent_title] => 'Modified vitamin K-dependent polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/955636
[patent_app_country] => US
[patent_app_date] => 1997-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 25
[patent_no_of_words] => 17529
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/017/06017882.pdf
[firstpage_image] =>[orig_patent_app_number] => 955636
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/955636 | Modified vitamin K-dependent polypeptides | Oct 22, 1997 | Issued |
| 08/954340 | HUMAN URINARY INCONTINENCE AND METHODS OF TREATMENT | Oct 16, 1997 | Abandoned |
Array
(
[id] => 1585956
[patent_doc_number] => 06358921
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-19
[patent_title] => 'Antimicrobial peptide compositions and method'
[patent_app_type] => B1
[patent_app_number] => 08/949059
[patent_app_country] => US
[patent_app_date] => 1997-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 24632
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/358/06358921.pdf
[firstpage_image] =>[orig_patent_app_number] => 08949059
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/949059 | Antimicrobial peptide compositions and method | Oct 9, 1997 | Issued |
| 08/937117 | COMPOUNDS FOR DEACTIVATING PHOSPHOLAMBAN FUNCTION ON CA-ATPASE (PHOSPHOLAMBAN INHIBITORS) | Sep 23, 1997 | Abandoned |
Array
(
[id] => 3955662
[patent_doc_number] => 05935929
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => 'Methods for treating interstitial lung disease by using interleukin-9 and its antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/925348
[patent_app_country] => US
[patent_app_date] => 1997-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 4327
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/935/05935929.pdf
[firstpage_image] =>[orig_patent_app_number] => 925348
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/925348 | Methods for treating interstitial lung disease by using interleukin-9 and its antagonists | Sep 7, 1997 | Issued |
Array
(
[id] => 3960638
[patent_doc_number] => 05900404
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-04
[patent_title] => 'Chemical modification of proteins to improve biocompatibility and bioactivity'
[patent_app_type] => 1
[patent_app_number] => 8/911224
[patent_app_country] => US
[patent_app_date] => 1997-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6407
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/900/05900404.pdf
[firstpage_image] =>[orig_patent_app_number] => 911224
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/911224 | Chemical modification of proteins to improve biocompatibility and bioactivity | Aug 14, 1997 | Issued |
Array
(
[id] => 4137349
[patent_doc_number] => 06015789
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-18
[patent_title] => 'Combined use of GnRH agonist and antagonist'
[patent_app_type] => 1
[patent_app_number] => 8/894317
[patent_app_country] => US
[patent_app_date] => 1997-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64522
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 371
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/015/06015789.pdf
[firstpage_image] =>[orig_patent_app_number] => 894317
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/894317 | Combined use of GnRH agonist and antagonist | Aug 13, 1997 | Issued |
Array
(
[id] => 4134669
[patent_doc_number] => 06147186
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => 'Parathyroid hormone-related peptide analogs'
[patent_app_type] => 1
[patent_app_number] => 8/903497
[patent_app_country] => US
[patent_app_date] => 1997-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 8991
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/147/06147186.pdf
[firstpage_image] =>[orig_patent_app_number] => 903497
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/903497 | Parathyroid hormone-related peptide analogs | Jul 29, 1997 | Issued |
Array
(
[id] => 3939410
[patent_doc_number] => 05981485
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Human growth hormone aqueous formulation'
[patent_app_type] => 1
[patent_app_number] => 8/891823
[patent_app_country] => US
[patent_app_date] => 1997-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3458
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981485.pdf
[firstpage_image] =>[orig_patent_app_number] => 891823
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/891823 | Human growth hormone aqueous formulation | Jul 13, 1997 | Issued |
Array
(
[id] => 3942871
[patent_doc_number] => 05981698
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Antimicrobial polypeptides'
[patent_app_type] => 1
[patent_app_number] => 8/909433
[patent_app_country] => US
[patent_app_date] => 1997-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3930
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981698.pdf
[firstpage_image] =>[orig_patent_app_number] => 909433
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/909433 | Antimicrobial polypeptides | Jun 2, 1997 | Issued |
| 08/854943 | METHOD OF TREATING INSULIN INSENSITIVITY AND SYNDROME X | May 12, 1997 | Abandoned |
Array
(
[id] => 4137303
[patent_doc_number] => 06015786
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-18
[patent_title] => 'Method for increasing sex steroid levels using IGF or IGF/IGFBP-3'
[patent_app_type] => 1
[patent_app_number] => 8/837603
[patent_app_country] => US
[patent_app_date] => 1997-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10316
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/015/06015786.pdf
[firstpage_image] =>[orig_patent_app_number] => 837603
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/837603 | Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 | Apr 20, 1997 | Issued |
Array
(
[id] => 4086670
[patent_doc_number] => 06025368
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Method for treating the symptoms of chronic stress-related disorders using IGF'
[patent_app_type] => 1
[patent_app_number] => 8/805807
[patent_app_country] => US
[patent_app_date] => 1997-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7998
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025368.pdf
[firstpage_image] =>[orig_patent_app_number] => 805807
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/805807 | Method for treating the symptoms of chronic stress-related disorders using IGF | Feb 24, 1997 | Issued |
Array
(
[id] => 4417166
[patent_doc_number] => 06224895
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => 'Method for promoting ovulation, parturition, and lactation in mammals'
[patent_app_type] => 1
[patent_app_number] => 8/768981
[patent_app_country] => US
[patent_app_date] => 1996-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4420
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/224/06224895.pdf
[firstpage_image] =>[orig_patent_app_number] => 768981
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/768981 | Method for promoting ovulation, parturition, and lactation in mammals | Dec 17, 1996 | Issued |
Array
(
[id] => 4099234
[patent_doc_number] => 06066489
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-23
[patent_title] => 'Method for treating blood borne viral pathogens such as immunodeficiency virus'
[patent_app_type] => 1
[patent_app_number] => 8/708083
[patent_app_country] => US
[patent_app_date] => 1996-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7806
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/066/06066489.pdf
[firstpage_image] =>[orig_patent_app_number] => 708083
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/708083 | Method for treating blood borne viral pathogens such as immunodeficiency virus | Aug 29, 1996 | Issued |
Array
(
[id] => 4247780
[patent_doc_number] => 06136781
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => 'LH-RH receptor antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/656244
[patent_app_country] => US
[patent_app_date] => 1996-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58729
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136781.pdf
[firstpage_image] =>[orig_patent_app_number] => 656244
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/656244 | LH-RH receptor antagonists | Jun 5, 1996 | Issued |
Array
(
[id] => 4131660
[patent_doc_number] => 06034059
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-07
[patent_title] => 'Treatment of catabolic states using authentic IGF-1 and hypocaloric amount of nutrients'
[patent_app_type] => 1
[patent_app_number] => 7/979863
[patent_app_country] => US
[patent_app_date] => 1993-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 3271
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/034/06034059.pdf
[firstpage_image] =>[orig_patent_app_number] => 979863
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/979863 | Treatment of catabolic states using authentic IGF-1 and hypocaloric amount of nutrients | Mar 16, 1993 | Issued |
Array
(
[id] => 4174318
[patent_doc_number] => 06083915
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'Method for treating liver cancer'
[patent_app_type] => 1
[patent_app_number] => 7/698681
[patent_app_country] => US
[patent_app_date] => 1991-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10800
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 894
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/083/06083915.pdf
[firstpage_image] =>[orig_patent_app_number] => 698681
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/698681 | Method for treating liver cancer | May 9, 1991 | Issued |